Internal Medicine · Hartford, CT
NPI
1386621464
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
85 Seymour St, Suite 1000
Hartford, CT, 06106
Phone (860) 246-2571
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
589 services
Medicare patients, 2024
327
Average age 72
Drug cost, 2024
$1.2M
1,488 prescriptions
Company payments, 2025
$112K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Colin T Swales was code 99232 (hospital e&m - subsequent), 133 times for 78 patients. In total Colin T Swales billed 589 services in 45 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 133 | 78 | $64.23 | $8,542 |
| 45385 Colonoscopy - Lesion Removal | Facility | 61 | 60 | $197.86 | $12K |
| 99222 Hospital E&M - Initial | Facility | 49 | 49 | $102.81 | $5,038 |
| 43239 Upper GI Endoscopy | Facility | 41 | 40 | $76.08 | $3,119 |
| 99214 Office E&M - Established | Office | 40 | 36 | $94.11 | $3,764 |
| 99214 Office E&M - Established | Facility | 32 | 30 | $67.41 | $2,157 |
| 99213 Office E&M - Established | Facility | 31 | 28 | $50.63 | $1,570 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 23 | 22 | $4.40 | $101 |
| 99231 Hospital E&M - Subsequent | Facility | 19 | 13 | $40.67 | $773 |
| 45380 Lower GI Endoscopy - Other | Facility | 17 | 17 | $121.91 | $2,073 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 12 | 12 | $189.61 | $2,275 |
| 99204 Office E&M - New | Facility | 12 | 12 | $100.74 | $1,209 |
By year: 2022 $99K for 2,356 services; 2023 $68K for 1,257 services; 2024 $59K for 589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Colin T Swales prescribed most often to Medicare patients was Pantoprazole Sodium, with 146 prescriptions and refills. In total Colin T Swales wrote 1,488 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 146 | 366 | 44 | $1,777 |
| Ursodiol Generic | 141 | 312 | 35 | $28K |
| Tacrolimus Generic | 115 | 217 | 19 | $16K |
| Lactulose Generic | 74 | 94 | 15 | $2,283 |
| Carvedilol Generic | 72 | 150 | 27 | $347 |
| Ocaliva Obeticholic Acid | 71 | 99 | Under 11 | $751K |
| Omeprazole Generic | 70 | 192 | 19 | $1,396 |
| Furosemide Generic | 62 | 139 | 18 | $156 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 61 | 61 | 61 | $10K |
| Spironolactone Generic | 60 | 134 | 19 | $515 |
| Mycophenolate Mofetil Generic | 52 | 90 | 11 | $4,914 |
| Xifaxan Rifaximin | 45 | 45 | Under 11 | $132K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 31 | 31 | 29 | $1,899 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 30 | 30 | 29 | $509 |
| Linzess Linaclotide | 28 | 44 | Under 11 | $23K |
Brand drugs: 345 claims; generic drugs: 1,143 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Colin T Swales $112K ($112K in general payments such as food, travel and fees) from 26 companies. The largest payer was Madrigal Pharmaceuticals with $65K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 40 | $65K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 16 | $19K |
| Intercept Pharmaceuticals, Inc. | 23 | $18K |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $7,323 |
| Janssen Biotech, Inc. JNJ | 15 | $514 |
| Gilead Sciences, Inc. GILD | 24 | $385 |
| Abbvie Inc. ABBV | 11 | $180 |
| Amgen Inc. AMGN | 2 | $143 |
| Phathom Pharmaceuticals, Inc. PHAT | 13 | $127 |
| Novo Nordisk Inc NVO | 1 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.